Introduction
============

Peroperative myocardial infarction (MI) which is detected by troponin I is the most common cause of morbidity and mortality ([@b1]). What is the role of general anesthesia in this process? Is general anesthesia a risk for MI?

Anesthesia directly causes myocardial depression and also effects vascular tonus and myocardial contractibility by autonomic nervous system or by hypoxia, hypercapnia, and acidosis depress myocardium ([@b6]; [@b16]). Apart from anesthesia, complications such as surgery, bleeding, infection, fever, and emboli also increase cardiac load. In the absence of cardiac disease, either myocardium may not tolerate this additional stress and failure or ischemia may develop. In order to decrease postoperative mortality and morbidity, risks must be determined and prevented.

We tried to determine the cardiac injury, in three periods (pre-, per- and postoperative), and we realized that it has no side effects after using isofluran + N~2~O inhalation and propofol + fentanyl intravenous anesthesia in healthy patients who underwent noncardiac surgery.

Method
======

The study was conducted with the permission of the faculty etiquette committee. All patients were informed and consented. Elective abdominal hysterectomy was planned in 40 patients who were 20--45 years range, in ASA-I group and Goldman Cardiac Risk Index-0. The patients were admitted to operation room without premedication, monitorization, and vital parameters (TA, pulse, arterial O~2~ saturation) were recorded. Two venous catheters were placed on each hand, blood samples were taken from one, and fluid was given into the other. The patients were divided into two groups. Each group was formed by 20 patients. Inhalation anesthesia was administrated to the first group, and intravenous anesthesia to the second. After induction with thiopental sodium (4--7 mg/kg) + fentanyl (1 μ/kg), inhalation anesthesia was maintained by isofluran 1.5% + N~2~O/O~2~ (50%/50%). In the second group, after induction with propofol (3 mg/kg) and fentanyl (5 μg/kg), anesthesia was maintained by propofol (0.2 mg/kg/min) and fentanyl (0.2 μg/kg/min). The patients in this group were ventilated by 50% O~2~ and 50% air. Muscle relaxation was provided by vecuronium bromide (0.1 mg/kg) in both groups, and mechanical ventilation was applied as follows: V~T~: 8--10 ml/kg, f: 10--12 min, P~max~ 20--30 mbar, PEEP: O mbar, T~1/E~: 1/1.7 monitorization and ventilation was obtained from DRÄGER Cato 8040 anesthesia machine and perfusion by Compact B BRAUN perfuser.

Three blood samples were taken from patients, before anesthesia, after induction before surgery and 9 hours after second period. Blood samples were taken into sterile tubes which did not contain EDTA and heparin in order to avoid low results, and they were centrifuged and stored in −20 °C.

Cardiac troponin I levels were calculated by ng/ml with solid phase, two-site chemluminescent immunometric assay method in Immulite Automated Analyser. Normal Range: \<0.4ng/ml. Statistical analysis was performed by SPSS for Windows (Microsoft, Redmond, Washington DC). All results are expressed as mean ±SD except as stated otherwise. p values under 0.05 (p \< 0.05) were accepted statistically significant. T-test was used as the groups have parametric and independent conditions.

Results
=======

Groups were similar according to age, body weight and gender ([Table 1](#tbl1){ref-type="table"}).

###### 

Demographic properties (mean ± standard error)

  --------------------------------------------------------
  Group              Inhalation\    Intravenous\   p
                     (n = 10)       (n = 10)       
  ------------------ -------------- -------------- -------
  Age (year)         39.27 ± 8.45   40.27 ± 1.70   0.747

  Body weight (kg)   68.64 ± 1.74   69.73 ± 3.3    0.778

  Gender (f/m)       20/0           20/0           
  --------------------------------------------------------

Except for the pulse rates under anesthesia, there was no difference in the preanaesthetic and anaesthetic hemodynamic parameters of two groups (p \> 0.05) ([Table 2](#tbl2){ref-type="table"}). The pulse rates difference under anesthesia was attributed to the bradycardic effects of anaesthetic agent that was used in intravenous group.

###### 

Hemodynamic parameters

  Before induction                                                                           
  ------------------------------------------------------- ---------------- ----------------- ---------
  SBP (mm/Hg)                                             125.55 ± 4.36    128.18 ± 3.52     0.643
  DBP (mm/Hg)                                             76.73 ± 2.17     76.73 ± 2.17      0.272
  Pulse (/min)                                            82.00 ± 2.10     75.45 ± 2.71      0.071
  O~2~ Saturation (%)                                     96.55 ± 0.49     96.18 ± 0.48      0.604
                                                                                             
  Before surgery, after favorable anesthetic conditions                                      
  **Group**                                               **Inhalation**   **Intravenous**   **P**
                                                                                             
  SBP (mm/Hg)                                             128.27 ± 5.68    131.91 ± 4.20     0.612
  DBP (mm/Hg)                                             82.09 ± 1.81     80.91 ± 2.39      0.698
  Pulse (/min)                                            88.00 ± 3.00     77.09 ± 3.06      0.019\*
  O~2~ Saturation (%)                                     96.91 ± 0.34     97.00 ± 043       0.870

The cTnI levels were presented in [Table 3](#tbl3){ref-type="table"}. With p \> 0.05, there was no difference in troponin levels between groups.As the value for the troponin levels between preanaesthetic/anaesthetic and anaesthetic/postanaesthetic was p \> 0.05, there was no significant difference found ([Table 4](#tbl4){ref-type="table"}).

###### 

Cardiac troponin i levels (Normal range \<0.4 ng/ml)

  ---------------------------------------------------------------
                             Inhalation\   Intravenous\   P
                             (ng/ml)       (ng/ml)        
  -------------------------- ------------- -------------- -------
  Preanesthetic Troponin:    0.24 ± 0.03   0.21 ± 0.01    0.261

  Anesthetic Troponin:       0.23 ± 0.02   0.20 ± 0.00    0.199

  Postanesthetic Troponin:   0.21 ± 0.01   0.20 ± 0.01    0.206
  ---------------------------------------------------------------

###### 

Comparison of troponin levels between groups

  Groups                      P (Inhalation)   P (Intravenous)
  --------------------------- ---------------- -----------------
  Preanesthetic-anesthetic:   0.692            0.343
  Anesthetic-postanesthetic   0.476            0.406

Discussion
==========

We tried to determine the cardiac injury rate using cTnI blood levels through two different anesthesia techniques in preanaesthesic, anaesthetic, and postanaesthetic (9th hour) periods. Patients were selected from ASA-I group who have no cardiac risk factor, no drug usage, without metabolic and endocrine disorder. They were divided into the inhalation and intravenous group randomly. Demographically, no difference was found between two groups. Isofluran + N~2~O were preferred because of minimal cardiac depressive effects and propofol + fentanyl for best suppression in stress response. Muscle relaxation was ensured by vecuronium bromide in both groups, which had no cardiac side effects. Anesthetic pulse rates were determined lower comparing the hemodynamic parameters of both groups. This contributed to the vagal effect of fentanyl. As arterial blood pressure and O~2~ saturation were not different at the rare time, it was estimated that this effect did not influence cardiac hemodynamia. Troponin I blood samples collected in three periods was found in basal levels. There was no significant difference between the groups statistically.

Under physiological conditions, myocardium works to balance the O~2~ supply and needs O~2~, but in critical states such as anesthesia, myocardium exposes physiologic and pharmacologic distress. The increased O~2~ need is compensated by tachycardia, increased contractility, and left ventricle end-diastolic pressure. As myocardium satisfies the O~2~ need, in diastole this mechanism may cause ischemic attacks and myocardial injury. An anesthetic agent causes imbalance in this compensation mechanism. They may depress myocardium directly or changing the vascular tonus and myocardial contractility in the autonomic nervous system, changing cardiac rhythm-rate or hypoxia, hypercapnia and acidosis. Apart from anesthesia, cardiac load is increased by surgery, bleeding, infection, fever, and complications such as pulmonary emboli. Especially, among the older population, the incidence of ischemic heart disease in intensive care unit is higher. Developing surgery and anesthetic opportunities ensure more patients are operated upon and their mean lifetime increases. This means more patients with cardiac problems and anesthesia administration. Either in the absence of cardiac disease, anesthetic and surgical additional stress may cause failure ischemia ([@b5]).

The most common complication is myocardial necrosis and 3%--5% of patients are seen under risk. Many of them are silent subendocardial lesions, but in a shorter time, this may have life threatening effect on surgery patients. Cardiac evens usually occur after 48 hours from surgery. In the early postoperative period, increased left ventricle load and metabolic disorders were common, especially, the release of cathelocoliginergic mediators and increased hypercoaguability related to the effects of anesthesia on circulation and surgery stimulus. This change demolishes myocardial energy balance and causes left ventricular failure development. For this reason, in order to reduce mortality and morbidity related to cardiac complications, risks must be determined and measures must be taken ([@b10], [@b12]; [@b15]; [@b17]; [@b18]).

In the past 20 years, creatinine kinase mb (CK-MB) isoenzyme, which has been issued as a marker for this purpose, may also be positive in traumatic injuries, renal insufficiency, strokes and mypathies, has not been informative. In diagnosis Wu et al suggest that after 6--24 hours later from the onset of acute myocardial infarction (AMI) CK-MB has great sensitivity but in 24--48 hours the sensitivity is reduced ([@b19]; [@b4]). Although myoglubin is valuable in the early period, it is not specific to cardiac injury. [@b8] reported cTnl releasing in AMI. Many acceptable studies were performed about the sensitivity and specify of cTnl ([@b1], [@b2]) Diagnosis and postoperative management is presently based on assessment of cTnI ([@b5]). The European and American Cardiology Societies ([@b14]) have established cTnI as the gold standard for diagnosis of AMI and risk stratification for adverse cardiac events.

Experimental and clinical studies have extensively shown that all volatile anesthetic agents decrease myocardial loading conditions and contractility. Even the newer inhalational agents such as desflurane and sevoflurane seem to exhibit a similar dose-dependent depression of myocardial function ([@b13]). Those depressant effects decrease myocardial oxygen demand and may, therefore, have a beneficial role on the myocardial oxygen balance during myocardial ischemia. Recently, experimental evidence has demonstrated that in addition to these indirect protective effects, volatile anesthetic agents also have direct protective properties against reversible and irreversible ischemic myocardial damage ([@b10]).

As a result, general anesthesia is not a risk for MI to date, but eliminates risk factors and protection against cardiac hemodynamia.
